Background: Among manuscripts submitted to biomedical journals, randomized controlled trials (RCTs) form the backbone of evidence-based medicine. Hence, their protocol should be designed rigorously and their results should be reported clearly.
Introduction
Many manuscripts with various methodologies are submitted to biomedical journals annually. Among such manuscripts, randomized controlled trials (RCTs) are the backbone of evidence-based medicine. According to Bastian 
What's New
• Adherence to CONSORT among RCTs published in Iranian medical journals (in English and Persian) was not sufficient.
• Articles published in the CONSORTendorsing and non-CONSORT-endorsing journals did not adhere adequately to CONSORT. should be designed meticulously and their results should be reported clearly.
To improve the quality of RCT reporting, a group of methodologists, epidemiologists, statisticians, and researchers developed the Consolidated Standards of Reporting Trials (CONSORT) Statement in 1996, 2 which was updated in 2001 3 and then in 2010. 4 According to previous studies, the adherence of RCTs to the CONSORT Checklist was not sufficient. [5] [6] [7] [8] Indeed, although there have been few reports on the quality of pharmacological RCTs published in Iranian medical journals so far, all of them have reported poor adherence to the CONSORT Statement. [9] [10] [11] Given the rise in the number of articles published in Iran, 12, 13 we aimed to evaluate the extent of adherence to the CONSORT Statement in pharmacological RCTs published in Iranian medical journals from September 2012 to September 2013. We also sought to address the fact that there were no reports on the comparison of adherence to CONSORT between articles in English and in Persian.
On the other hand, some researchers have reported that adherence to CONSORT 2010 among CONSORT-endorsing journals is more sufficient than that among other journals. 5, [14] [15] [16] [17] [18] Therefore, we decided to assess adherence to CONSORT 2010 among articles published in Iranian CONSORT-endorsing medical journals in the mentioned period.
Materials and Methods
In this cross-sectional study, we analyzed the content of all published articles in all Iranian medical journals ranked as "scientific" by the Iranian Commission for Accreditation of Medical Journals, affiliated to the Iranian Ministry of Health and Medical Education from September 2012 to September 2013. Three out of 296 journals were excluded because their publishing date was not within this period, they had no accurate contact information, or they lacked an active website. One hundred twenty-three journals contained pharmacological RCTs. The title of each journal was searched via Google, Yahoo, Bing, and Web Search to retrieve articles meeting our inclusion criteria from the journal sites. Out of 14,964 articles published in the journals, 493 reported pharmacological interventions.
All RCTs with pharmacological interventions were selected based on the study design described in the method section of the articles, although the authors might have mistakenly described their studies as experimental, semiexperimental, quasi-experimental, interventional, case control, or even cohort studies. Some articles that mentioned no specific design were included if their study method was compatible with RCTs.
Non-randomized, community, crossover, field, non-human, and before-after trials were excluded.
In 44 articles, a pharmacological intervention was compared with a non-pharmacological or herbal intervention. Fourteen of these articles whose authors aimed to evaluate the efficacy of pharmacological interventions were included. Of all the pharmacological RCTs, 213 articles were written in the English language and 280 in the Persian language.
Additionally, the instructions for authors specified by all the mentioned journals were reviewed to determine whether or not they demanded implementation of the CONSORT Statement. Of 123 journals publishing pharmacological articles, 12 were CONSORTendorsing; all of them were in the English language.
The CONSORT Statement 2010 was downloaded from www.CONSORT-statement. org. 4 The original CONSORT Checklist has 25 items. Considering that some items consisted of several sections, we subdivided them to assess the RCTs more accurately. Accordingly, a checklist with 51 items was prepared and the articles were evaluated on the basis of whether or not they reported the items existing in the checklist.
Microsoft Excel 2007 was employed to enter and analyze the data. A score of 1 was allocated to the items reported and a score of 0 to those not reported. In case of the non-applicability of an item for reporting, the related cell in the software was only highlighted.
The frequencies and the percentiles for all the reported, not reported, and non-applicable items were calculated. The procedure was thereafter repeated for the English and Persian language articles and those published in the CONSORTendorsing and non-CONSORT-endorsing journals.
The χ 2 test was applied to compare the proportions of each item between the English and Persian language articles and between those published in the CONSORT-endorsing and non-CONSORT-endorsing journals. MedCalc (version 8.0.0.0, MedCalc Software, Belgium) was used for these comparisons. A P value less than 0.05 was considered statistically significant.
The confidentiality of the authors and journals was taken into consideration.
Results
In the mentioned period, 493 pharmacological RCTs were published in Iranian medical journals. Eleven articles only reported the setting of the study and the locations were not reported; of them 6 were in the Persian language and 5 in the English language. In 2 articles, no description was available for the second arm of the trial (1 in the English language and 1 in the Persian language articles).
A clear "hypothesis" was mentioned in only 24 articles (4 in the Persian language and 20 in the English language articles). Table 2 compares the items of non-adherence between the Persian and English language articles. The differences between the 2 groups were statistically significant in 17 items.
Thirty-two articles were published in CONSORT-endorsing journals. Table 3 compares the items of non-adherence between the CONSORT-endorsing and non-CONSORTendorsing journals. The differences between these 2 groups of journals were significant just in 8 items.
Discussion
In the present study, we drew upon CONSORT 2010 to evaluate pharmacological RCTs with respect to their adherence to all the 51 items of the checklist. We found that the evaluated articles could have adhered more to CONSORT 2010 had they been conducted more meticulously. Using a CONSORT 2010 Checklist with 37 items, Nojomi and colleagues 10 assessed the quality of reporting in RCTs published in Iranian medical journals from 2008 to 2010 and reported poor adherence among the articles; this finding chimes in with the results of our study. Nevertheless, there are differences between their study and ours. First, they used herbal and devised specific subcategories for each type. In this study, pharmacological studies are reported and presented. In another report from Iran, Ayatollahi et al. 9 focused on only 4 items of CONSORT in 25 Iranian medical journals. They reported no adherence to all those items in the assessed journals. Our study seems to be more comprehensive than the aforementioned ones because we surveyed all the items in all Iranian medical journals.
Hopewell and coworkers The results demonstrated that adherence to the items was poor. In contrast to our study, the researchers excluded non-English language articles and did not subcategorize the RCTs using specific types of CONSORT. 8 We compared adherence to the CONSORT 2010 Checklist between 280 Persian language articles and 213 English language articles and found that the differences between the 2 groups were statistically significant in 17 items. Most of these items were reported more frequently in the English language articles than in the Persian language ones. To the best of our knowledge, there are few studies comparing adherence to CONSORT between RCTs in the English language and other languages. 22, 23 Junker 23 compared RCTs conducted in German and English. Because the publication years of the evaluated articles predated the development of the CONSORT Checklist, the researcher did not use the CONSORT Statement and concluded that there was no difference between these 2 groups of RCTs. Klassen and others 22 compared quality between English and nonEnglish language (Danish, Dutch, French, German, Italian, Japanese, and Spanish) RCTs. They did not use CONSORT for the assessment because of the year of publication and arrived at the conclusion that the English language RCTs enjoyed better quality. We believe that using a structural guideline such as CONSORT to compare English language articles with nonEnglish language ones may yield more accurate findings. This approach can be the strength of our study. To our knowledge, since the development of the CONSORT Checklist, the present study is the first assessment and comparison of adherence to CONSORT between English and Persian RCTs. This is all but a truism that English language articles should be reported with acceptable quality because they are meant to be published in journals with international readers. Indeed, such articles should endeavor to report accurate information for citation and use in meta-analyses. In our study, although some items were reported more frequently in the English language articles, most of the items did not adhere to the checklist. It would, therefore, be reasonable to suggest that Iranian medical editors pay heed to the CONSORT guidelines as an important tool that can boost the visibility of their published RCTs.
Having evaluated 493 pharmacological RCTs published in 296 Iranian medical journals during a 1-year period, we can claim that the current study boasts the largest sample size of all the studies hitherto conducted in this field. In previous similar studies, only 80 journals, 10 25 journals, 9 4 high-impact-factor pharmacological journals, 20 4 high-rank journals, 24 5 high-rank journals, 7, 21 71 Japanese journals, 5 and 20 RCTs published in the Journal of Cardiology 25 were evaluated. In light of the aforesaid studies, we can assert that another salient strong point of our study is the evaluation of a larger number of articles and journals.
Low adherence to the CONSORT Statement among the RCTs in our selected journals by comparison with those published in highrank journals reported by Ahmadzadeh and colleagues, 21 Mills and others, 7 and Han et al. 26 can be explained by the fact that high-rank journals usually receive and select RCTs with the utmost quality. A developing country with a considerable number of journals, Iran can be representative of other countries in the Eastern Mediterranean Region. Therefore, our findings propose poor adherence to CONSORT in published pharmacological RCTs can be generalized to other RCTs published in other regional countries. It is worth mentioning that the Iranian Ministry of Health and Medical Education attaches great significance to enhancing the quality of articles published in Iranian medical journals. The fact that despite such emphasis the quality of RCTs in our region falls short of the standards set by high-rank journals underscores the need for more rigorous supervision.
We did not calculate the average adherence of the evaluated RCTs compared with what Nojomi, Ahmadzadeh, and Han and others did. 10, 21, 26 We think that each item in the CONSORT Checklist carries a significant weight. For example, randomization, blinding, sample size determination, flow diagram, and registration number are important methodological items that can weigh differently in different studies; hence, reporting the whole score may not show the overall quality of the reported RCTs.
In the present study, we compared adherence between RCTs published in CONSORTendorsing journals and those published in non-CONSORT-endorsing ones and found that the 2 groups were meaningfully different in terms of adherence in 8 items. All of the 8 items were reported more frequently in the articles published in the CONSORT-endorsing journals. Overall, adherence to the CONSORT 2010 Checklist was not sufficient in the 2 groups.
Pandis et al. 18 in their study concluded that the articles published in the period after the implementation of CONSORT reported more items. Miller and others 27 compared general medical journals and specialty journals that endorsed CONSORT and concluded that both groups failed to properly implement CONSORT in reporting trials. Turner and coworkers 17 compared RCTs published in CONSORTendorsing journals with those published in non-CONSORT-endorsing journals and concluded that the former group might help authors to report more adherent RCTs, although it did not mean that the RCTs published in CONSORTendorsing journals were reported sufficiently.
First and foremost among the strengths of the current study is that we assessed all the 25 items of the CONSORT Statement together with all their respective subcategories. Such comprehensive evaluation has not yet been done on the CONSORT guidelines. There are, nevertheless, some limitations in our study. When the websites of some journals were not available, we referred to www.magiran.com or www.sid.org. Whenever we found articles comparing drug interventions with herbal or non-pharmacological interventions we used a checklist suitable for the dominant intervention. Another drawback of note is that the low number of the articles published in CONSORT-endorsing journals may have affected the results of the comparisons.
Conclusion
Adherence to the CONSORT Statement among our selected RCTs, published in Persian and English in Iranian medical journals, was not sufficient. In addition, the articles published in both CONSORT-endorsing and non-CONSORTendorsing journals failed to adhere to CONSORT adequately. We would recommend that authors, reviewers, and editors seek out further training in the proper implementation of the CONSORT statement and that editors be sure to endorse CONSORT in their instructions for authors and monitor adherence to it. What would also be beneficial is the development of a checklist suitable for reporting pharmacological interventions comparing herbal, non-pharmacological, and acupunctural interventions.
